Longevity Gene Transfer from Naked Mole Rat to Mice Extends Lifespan, Scientists Announce
Breakthrough Gene Transfer Extends Lifespan in Mice
Scientists at the University of Rochester have successfully transferred a longevity gene from the naked mole rat—one of the longest-living rodents—into mice, dramatically improving their health and lifespan. The modified mice showed stronger resistance to tumors, healthier intestines, and reduced age-related inflammation, according to a study published today.
"This is a major step in understanding how aging can be slowed at the molecular level," said Dr. Vera Gorbunova, co-author of the study. "We've shown that a single gene from an exceptionally long-lived species can have profound effects on lifespan and health in another mammal."
The Key Molecule: High Molecular Weight Hyaluronic Acid
The transferred gene boosts production of high molecular weight hyaluronic acid (HMW-HA), a substance that naturally occurs in naked mole rats at elevated levels. HMW-HA appears to protect against cancer, reduce chronic inflammation, and support healthier aging throughout the body.
"The mice that received the gene not only lived longer but also showed significantly lower rates of cancer and maintained better gut health," said Dr. Gorbunova. "This is the first direct evidence that HMW-HA can be transferred between species to extend lifespan."
Background: Why Naked Mole Rats?
Naked mole rats are a biological marvel—they can live up to 30 years, far exceeding other rodents of similar size, and rarely develop cancer. Their cells produce exceptionally high levels of HMW-HA, which contributes to their resilience.
The University of Rochester team used gene editing to insert the naked mole rat's hyaluronan synthase 2 gene into mouse embryos. The resulting mice expressed the gene and produced HMW-HA in their tissues.
"We observed that these mice had lower oxidative stress, less inflammation, and fewer spontaneous tumors than wild-type mice," explained Dr. Andrei Seluanov, co-author of the study. "Their overall healthspan was markedly improved."
What This Means for Human Aging
The success in mice raises the tantalizing possibility that similar therapies could one day be developed for humans. If scientists can safely increase HMW-HA levels in people, it might help prevent age-related diseases such as cancer, arthritis, and cardiovascular conditions.
"This demonstrates that mechanisms from exceptionally long-lived species can be harnessed for potential human benefit," said Dr. David Sinclair, an aging researcher at Harvard Medical School who was not involved in the study. "But we must be cautious—what works in mice may not transfer directly to humans."
Future research will focus on understanding the exact molecular pathways through which HMW-HA extends lifespan and on developing drugs or gene therapies that can safely boost its production in humans. The team also plans to test the gene in other animal models.
"We are still years away from clinical applications," cautioned Dr. Gorbunova. "But this experiment shows that aging is not an irreversible process—it can be modulated by specific genes."
Back to topRelated Articles
- Immunotherapy Before Surgery: A New Hope for Colorectal Cancer Patients
- 10 Key Insights into Akeso's Ivonescimab and Its ASCO Plenary Spotlight
- Healthcare Startup Survival: A Practical Guide to FDA Approval, Fundraising, and Team Resilience
- 10 Key Shifts in Trump’s Surgeon General Pick and What They Mean for Your Health
- PFAS in Baby Formula: What the Latest FDA Testing Reveals
- How to Enhance Breast Cancer Therapy with Vitamin D: A Practical Guide
- From One Miracle to Many: Julia Vitarello's Quest to Scale Personalized Medicine
- How to Leverage Apple’s AirPods Hearing Health Features Based on the Latest Apple Hearing Study Findings